tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Demyelinating Diseases D003711 15 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Crohn Disease D003424 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Thyroid Diseases D013959 8 associated lipids
Sinusitis D012852 9 associated lipids
Leukocytosis D007964 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Hypoglycemia D007003 13 associated lipids
Hemolytic-Uremic Syndrome D006463 2 associated lipids
Pancytopenia D010198 6 associated lipids
Nervous System Diseases D009422 37 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Brain Edema D001929 20 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Gingivitis D005891 3 associated lipids
Periodontal Pocket D010514 9 associated lipids
Brain Infarction D020520 17 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Nephrotic Syndrome D009404 11 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Ischemia D007511 18 associated lipids
Glycosuria D006029 10 associated lipids
Seizures D012640 87 associated lipids
Neuromuscular Diseases D009468 10 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Dermatitis D003872 30 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Vomiting D014839 21 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Pharyngitis D010612 2 associated lipids
Shock D012769 11 associated lipids
Erythema D004890 22 associated lipids
Dermatomycoses D003881 17 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Cholelithiasis D002769 16 associated lipids
Fever D005334 35 associated lipids
Amenorrhea D000568 4 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Thrombocytopenia D013921 15 associated lipids
Hyperlipidemias D006949 73 associated lipids
Shock, Septic D012772 11 associated lipids
Ileal Neoplasms D007078 2 associated lipids
Cough D003371 19 associated lipids
Paraproteinemias D010265 2 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Catalepsy D002375 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Ovarian Cysts D010048 4 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Cardiomegaly D006332 31 associated lipids
Hypertension, Renal D006977 9 associated lipids
Metaplasia D008679 7 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Tachycardia D013610 7 associated lipids
Cicatrix D002921 9 associated lipids
Neutropenia D009503 15 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Urticaria D014581 13 associated lipids
Behcet Syndrome D001528 7 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Thrombophlebitis D013924 6 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
HIV Seropositivity D006679 15 associated lipids
Uveitis D014605 14 associated lipids
Enterobacteriaceae Infections D004756 5 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Oberholzer J et al. Daclizumab as escape therapy for late acute kidney rejection in the presence of FK506 nephrotoxicity. 2000 Transpl. Int. pmid:10836657
Yoshikawa T et al. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: immunosuppressive and osteogenic potential of FK506 in vivo. 2000 J. Bone Miner. Res. pmid:10841184
Rabinowitz M et al. Solid-phase/solution-phase combinatorial synthesis of neuroimmunophilin ligands. 2000 Bioorg. Med. Chem. Lett. pmid:10843203
Nasr IS Topical tacrolimus in dermatology. 2000 Clin. Exp. Dermatol. pmid:10844509
Samsonov D et al. Enhancement of immune tolerance via induction of NK1.1 positive liver-associated-lymphocytes under immunosuppressive conditions. 2000 J. Hepatol. pmid:10845669
Zhang F et al. Resistance to Friend murine leukemia virus infection conferred by the Fv-4 gene is recessive but appears dominant from the effect of the immune system. 2000 J. Virol. pmid:10846105
Small bowel transplants in adults and multivisceral transplants in adults and children. 1999 Tecnologica MAP Suppl pmid:10848042
Tyedmers J et al. Assembly of heterodimeric luciferase after de novo synthesis of subunits in rabbit reticulocyte lysate involves hsc70 and hsp40 at a post-translational stage. 2000 Eur. J. Biochem. pmid:10848974
Gibson SW et al. Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506. 2000 Transplantation pmid:10852592
Konrad T et al. Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy. 2000 Transplantation pmid:10852599
Schvarcz R et al. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). 2000 Transplantation pmid:10852623
Rollins CT et al. A ligand-reversible dimerization system for controlling protein-protein interactions. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10852943
Florio G et al. The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils. 2000 AIDS pmid:10853974
Kochi S et al. Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. 2000 Life Sci. pmid:10855946
Bultynck G et al. Effects of the immunosuppressant FK506 on intracellular Ca2+ release and Ca2+ accumulation mechanisms. 2000 J. Physiol. (Lond.) pmid:10856121
Granot E et al. Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation. 2000 Transplant. Proc. pmid:10856551
Ben-Ari Z et al. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy. 2000 Transplant. Proc. pmid:10856553
Barak S et al. Alveolar bone height in patients after liver transplantation. 2000 Transplant. Proc. pmid:10856558
Gotsman I et al. Effect of peripheral immune tolerance on liver-associated lymphocytes expressing NK1.1. 2000 Transplant. Proc. pmid:10856569
Malinowski K et al. Effect of different anti-rejection regimens on the expression of differentiation and activation markers on the surface of host lymphocytes. 2000 Transplant. Proc. pmid:10856579
McLaughlin GE et al. Effect of aminophylline on urine flow in children with tacrolimus-induced renal insufficiency. 2000 Transplant. Proc. pmid:10856596
Morelli AE et al. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus. 2000 J. Immunol. pmid:10861056
Boubenider S et al. Interaction between theophylline and tacrolimus in a renal transplant patient. 2000 Nephrol. Dial. Transplant. pmid:10862651
Wu K et al. The FK520 gene cluster of Streptomyces hygroscopicus var. ascomyceticus (ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units. 2000 Gene pmid:10863099
Oike F et al. A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. 2000 Transplantation pmid:10868630
Yamani MH et al. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. 2000 Transplantation pmid:10868634
Blakolmer K et al. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. 2000 Transplantation pmid:10868635
Neuhaus P et al. Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial. 2000 Transplantation pmid:10868638
Au WY et al. Tacrolimus (FK 506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin. 2000 Haematologica pmid:10870125
Queille-Roussel C et al. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. 2000 Contact Derm. pmid:10871099
Morales JM et al. Immunosuppression in older renal transplant patients. 2000 Drugs Aging pmid:10874523
Costantini LC and Isacson O Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture. 2000 Exp. Neurol. pmid:10877916
Castilho RF et al. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons. 2000 Exp. Neurol. pmid:10877919
Allison AC Immunosuppressive drugs: the first 50 years and a glance forward. 2000 Immunopharmacology pmid:10878284
Assmann T et al. Applications of tacrolimus for the treatment of skin disorders. 2000 Immunopharmacology pmid:10878290
Hamazaki T et al. [Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors]. 2000 Rinsho Ketsueki pmid:10879106
Ben Abraham R et al. [FK506 (tacrolimus) does not increase hepatic damage due to hypoperfusion]. 2000 Harefuah pmid:10883243
Romano G et al. Systemic and intratubular effects of cyclosporin-A and tacrolimus on the rat kidney. 2000 Eur. J. Pharmacol. pmid:10884522
Parker EM et al. Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression. 2000 Neuropharmacology pmid:10884572
Terashima A et al. Rapamycin and FK506 induce long-term potentiation by pairing stimulation via an intracellular Ca(2+) signaling mechanism in rat hippocampal CA1 neurons. 2000 Neuropharmacology pmid:10884573
Zaman AK Effects of tacrolimus hydrate (FK-506) on the expression of tissue factor in THP-1 human monocyte cell line. 2000 Hokkaido Igaku Zasshi pmid:10884973
Arthur JM and Shamim S Interaction of cyclosporine and FK506 with diuretics in transplant patients. 2000 Kidney Int. pmid:10886578
Hooijberg E et al. NFAT-controlled expression of GFP permits visualization and isolation of antigen-stimulated primary human T cells. 2000 Blood pmid:10887106
Mori A et al. Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors. 2000 J. Allergy Clin. Immunol. pmid:10887335
Yue G et al. The effect of rapamycin on single ENaC channel activity and phosphorylation in A6 cells. 2000 Am. J. Physiol., Cell Physiol. pmid:10898719
Mukerjee N et al. Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. 2000 Arch. Biochem. Biophys. pmid:10898953
Hishinuma S and Ogura K Ca(2+)/calmodulin-mediated regulation of the desensitizing process in G(q) protein-coupled histamine H(1) receptor-mediated Ca(2+) responses in human U373 MG astrocytoma cells. 2000 J. Neurochem. pmid:10899954
Wang L et al. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. 2000 Clin. Exp. Pharmacol. Physiol. pmid:10901387
Fisher NC et al. The clinical impact of nephrotoxicity in liver transplantation. 2000 Transplantation pmid:10910259
MacDonald AS Management strategies for nephrotoxicity. 2000 Transplantation pmid:10910262
Reyes J et al. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. 2000 Transplantation pmid:10910279
Shapiro AM et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. 2000 N. Engl. J. Med. pmid:10911004
Robertson RP Successful islet transplantation for patients with diabetes--fact or fantasy? 2000 N. Engl. J. Med. pmid:10911012
Ellis D Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants. 2000 Pediatr. Nephrol. pmid:10912544
Yang GS et al. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. 2000 Am J Otol pmid:10912694
Mancilla UE et al. Primary immunosuppression with tacrolimus in renal transplantation: a multicenter, open-label study. 1999 Sep-Oct Adv Ther pmid:10915396
Lee TJ and Kennedy LA Tacrolimus: an alternative for graft-versus-host disease prevention. 2000 Ann Pharmacother pmid:10917386
Nieto Y et al. Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation. 2000 Bone Marrow Transplant. pmid:10918414
Yanik G et al. Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. 2000 Bone Marrow Transplant. pmid:10918426
Peduto G et al. Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. 2000 Transplantation pmid:10919579
Younes BS et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. 2000 Transplantation pmid:10919581
Higgins RM et al. Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. 2000 Transplantation pmid:10919600
Puig I Marí JM et al. Reflex sympathetic dystrophy syndrome of the lower limbs in a renal transplant patient treated with tacrolimus. 2000 Transplantation pmid:10919604
Reitamo S et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. 2000 Arch Dermatol pmid:10926735
Sugiura H et al. Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis. 2000 Arch Dermatol pmid:10926750
Sakuma S et al. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells. 2000 Br. J. Pharmacol. pmid:10928971
Jimenez J and Young JB Clinical challenges in thoracic organ transplantation: case studies in immunosuppressive therapy. 2000 J. Heart Lung Transplant. pmid:10930823
Schmutz J et al. [Gingival hypertrophy and tacrolimus]. 2000 Jun-Jul Ann Dermatol Venereol pmid:10930868
Kung L and Halloran PF Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. 2000 Transplantation pmid:10933159
Gruber SA et al. Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. 2000 Transplantation pmid:10933170
Chin C et al. Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients. 2000 Pediatr Transplant pmid:10933319
Furlan V et al. Conversion from cyclosporin A to tacrolimus in pediatric liver transplantation. 2000 Pediatr Transplant pmid:10933321
Minamino T et al. Chronic treatment with FK506 increases p70 S6 kinase activity associated with reduced nitric oxide synthase activity in rabbit hearts. 2000 Cardiovasc Drugs Ther pmid:10935155
Watanabe T et al. Effects of the endothelin-1 receptor antagonist TAK-044 on pulmonary injury in discordant xenotransplantation. 2000 Transplant. Proc. pmid:10936270
Takayama K et al. Hepatocyte growth factor and vascular endothelial growth factor expression in pig-to-primate xenotransplanted hearts. 2000 Transplant. Proc. pmid:10936314
Yin DP et al. Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. 2000 Transplant. Proc. pmid:10936320
Song Z et al. Protective effect of FK-506 in pig-to-rat islet xenotransplantation is abrogated by prednisolone. 2000 Transplant. Proc. pmid:10936332
Miki T et al. Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation. 2000 Transplant. Proc. pmid:10936339
Wada Y et al. Expression of the transcriptional factor egr-1/BTEB2 in cardiac xenograft vascular remodeling. 2000 Transplant. Proc. pmid:10936371
Takayama K et al. Nonmuscle myosin heavy chain and nuclear factor-kappa B expression in pig-to-primate xenotransplanted hearts. 2000 Transplant. Proc. pmid:10936372
Goller AL et al. Loss of serum bicarbonate after discordant liver xenotransplantation. 2000 Transplant. Proc. pmid:10936383
Endoh M et al. Nonmuscle myosin heavy chain and metalloproteinase-2 expression in concordant pulmonary xenografts. 2000 Transplant. Proc. pmid:10936397
Matsuda S and Koyasu S [A second target of cyclosporin A and FK506]. 2000 Tanpakushitsu Kakusan Koso pmid:10936966
Uchida N et al. Myocardial ischemia following allogeneic bone marrow transplantation: possible implication of tacrolimus overdose. 2000 Blood pmid:10939803
Casson DH et al. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. 2000 Gut pmid:10940284
Bertram PG et al. Tripartite regulation of Gln3p by TOR, Ure2p, and phosphatases. 2000 J. Biol. Chem. pmid:10940301
Woltman AM et al. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. 2000 Eur. J. Immunol. pmid:10940869
Bunn SK et al. Treatment of microvillus inclusion disease by intestinal transplantation. 2000 J. Pediatr. Gastroenterol. Nutr. pmid:10941971
Hübner GI and Sziegoleit W Response to letter from van Gelder. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. 2000 Ther Drug Monit pmid:10942194
Flores F and Kerdel FA Other novel immunosuppressants. 2000 Dermatol Clin pmid:10943542
Youn HD et al. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. 2000 EMBO J. pmid:10944115
Misseghers BS et al. Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs. 2000 Can. Vet. J. pmid:10945128
Masuda S et al. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient. 2000 Clin. Pharmacol. Ther. pmid:10945321
Sheiner PA Hepatitis C after liver transplantation. 2000 Semin. Liver Dis. pmid:10946424
Li WE and Nagy JI Connexin43 phosphorylation state and intercellular communication in cultured astrocytes following hypoxia and protein phosphatase inhibition. 2000 Eur. J. Neurosci. pmid:10947839
Kohlhaw K et al. [Clinical studies in liver transplantation]. 2000 Chirurg pmid:10948733
Shoker A et al. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. 2000 Transplantation pmid:10949194
Straatman LP and Coles JG Pediatric utilization of rapamycin for severe cardiac allograft rejection. 2000 Transplantation pmid:10949201
Verleden GM Bronchiolitis obliterans syndrome after lung transplantation: medical treatment. 2000 Monaldi Arch Chest Dis pmid:10949876
Jones JW et al. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. 2000 N. Engl. J. Med. pmid:10950668